Reduced folate carrier protein expressio
โ
Ilan Ifergan; Issac Meller; Josefin Issakov; Yehuda G. Assaraf
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 178 KB
## Abstract ## BACKGROUND Highโdose methotrexate (MTX) is an important component of current protocols for the treatment of osteosarcoma. Although MTX uptake proceeds primarily through the reduced folate carrier (RFC) protein and efflux occurs via multidrug resistance protein 1 (MRP1), RFC protein